Organization
Korean Cancer Study Group
2 clinical trials
Clinical trial
A Phase lb/ll, Multicenter, Open Label, Single Arm Study to Assess the Safety and Efficacy of the Anti-VEGFR2 Monoclonal Antibody Olinvacimab and the Capecitabine in Patients With mCRC Who Failed Two Prior ChemotherapiesStatus: Withdrawn, Estimated PCD: 2023-10-31
Clinical trial
A Phase lb/ll, Open Label, Single Arm Study to Assess Efficacy and Safety of Alpelisib and Capecitabine in Patients With PIK3CA Mutant Metastatic Colorectal Cancer Who Failed Two Prior Standard ChemotherapiesStatus: Active (not recruiting), Estimated PCD: 2024-02-28